Takeda Launches Adynovate To Advance Prophylaxis Treatment For Hemophilia Patients in India
Takeda Launches Adynovate To Advance Prophylaxis Treatment For Hemophilia Patients in India An extended half-life recombinant Factor VIII (rFVIII) treatment for hemophilia A, resulting in lower weekly infusion rates than …
Takeda Launches Adynovate To Advance Prophylaxis Treatment For Hemophilia Patients in India Read More